Shasun Pharmaceuticals Ltd(Merged)

Shasun Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shasun Pharmaceuticals Ltd(Merged)

₹ 429 5.40%
17 Nov 2015
shasun.com BSE: 524552
About

Shasun Pharmaceuticals Limited (SPL) is an India-based company, which is a supplier of development and manufacturing services for intermediates, active pharmaceutical ingredients (API) and finished dosage. The Company is also into product development and provides contract research and manufacturing services.

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 429
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 72.0
  • Dividend Yield 0.00 %
  • ROCE 10.5 %
  • ROE 10.8 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 5.95 times its book value
  • Tax rate seems low
  • Company has a low return on equity of 10.6% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015 Jun 2015 Sep 2015
199 197 209 176 223 247 289 250 280 273 275 258 268
179 189 190 170 198 221 257 231 252 233 250 230 238
Operating Profit 20 8 19 6 25 25 32 19 28 40 25 27 31
OPM % 10% 4% 9% 3% 11% 10% 11% 8% 10% 15% 9% 11% 11%
9 8 2 1 3 3 5 2 4 1 8 2 4
Interest 5 8 6 7 8 9 12 10 11 13 12 10 10
Depreciation 8 7 10 9 10 9 11 8 10 9 10 11 12
Profit before tax 17 1 6 -8 12 10 14 4 12 19 11 8 13
Tax % 21% -160% -75% -132% 0% -1% 21% 0% 0% 0% 39% 9% 11%
13 3 10 3 12 10 11 4 12 19 7 7 12
EPS in Rs 2.37 0.52 1.82 0.44 2.04 1.79 1.95 0.61 1.94 3.18 1.15 1.04 1.75
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 TTM
341 395 422 456 531 567 736 782 929 1,076 1,074
286 339 408 471 492 528 712 714 834 968 951
Operating Profit 55 57 14 -14 39 39 24 68 95 108 123
OPM % 16% 14% 3% -3% 7% 7% 3% 9% 10% 10% 11%
17 15 44 18 28 16 68 14 12 29 15
Interest 5 6 7 14 20 22 30 26 42 54 45
Depreciation 23 25 27 27 26 24 25 32 38 37 42
Profit before tax 43 40 24 -38 20 8 37 24 28 46 51
Tax % 15% 5% 9% -11% -9% 42% -42% -11% -26% 10%
36 38 22 -33 22 5 53 26 35 41 45
EPS in Rs 7.96 4.62 -6.91 4.57 1.01 9.63 4.64 6.22 6.88 7.12
Dividend Payout % 22% 21% 22% 0% 22% 30% 25% 32% 16% 0%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 13%
TTM: 1%
Compounded Profit Growth
10 Years: %
5 Years: 14%
3 Years: 9%
TTM: 20%
Stock Price CAGR
10 Years: 3%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 11%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015
Equity Capital 10 10 10 10 10 10 11 11 11 12
Reserves 170 199 216 183 199 162 251 274 305 402
79 103 135 210 215 219 238 403 533 586
94 112 107 126 133 174 212 227 290 318
Total Liabilities 354 423 468 528 556 565 712 915 1,139 1,319
175 178 175 164 147 166 194 267 277 426
CWIP 2 10 39 29 31 5 31 81 102 66
Investments 6 25 44 44 1 2 5 51 57 62
171 210 210 291 377 391 482 516 704 764
Total Assets 354 423 468 528 556 565 712 915 1,139 1,319

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015
31 53 48 -33 45 35 10 10 66 76
-32 -56 -69 -20 -23 -17 -48 -147 -140 -140
-9 6 19 55 -16 -19 37 134 81 56
Net Cash Flow -10 4 -3 2 6 -1 -2 -3 6 -8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015
Debtor Days 98 110 108 147 129 89 98 103 112 101
Inventory Days 91 85 64 59 67 109 86 109 124 123
Days Payable 77 94 68 98 128 122 125 133 157 144
Cash Conversion Cycle 113 100 104 108 68 76 59 80 79 79
Working Capital Days 99 101 101 138 167 96 83 111 109 132
ROCE % 16% 9% -6% 9% 8% 9% 8% 9% 10%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports